How is the Foghorn Therapeutics Inc today?

The Foghorn Therapeutics Inc today is trading in the down by 0.00% at 4.14.

What is Foghorn Therapeutics Inc Annual Revenue?

Foghorn Therapeutics Inc Annual Revenue fell 33.83%, in the last year to $22.6 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Foghorn Therapeutics Inc Annual Net Profit?

Foghorn Therapeutics Inc Annual Net Profit rose 11.99% in the last year to $86.62 M. Its sector's average net profit growth for the last fiscal year was -11.1%.

What is Foghorn Therapeutics Inc Price to Earning Ratio?

Foghorn Therapeutics Inc Price to Earning Ratio is -2.87, which is negative.

What is Foghorn Therapeutics Inc Stock Price?

Foghorn Therapeutics Inc Stock Price fell 33.44% and underperformed its sector by 52.11% in the past year.

What is Foghorn Therapeutics Inc Quarterly Revenue?

Foghorn Therapeutics Inc Quarterly Revenue rose 17.86% YoY to $5.95 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Foghorn Therapeutics Inc Quarterly Net profit?

Foghorn Therapeutics Inc Quarterly Net profit rose 24.71% YoY to $18.83 M. Its sector's average net profit growth YoY for the quarter was -213.16%.

What is Foghorn Therapeutics Inc Mutual Fund Holding?

Foghorn Therapeutics Inc Mutual Fund Holding decreased by 0.15% in the last quarter to 21.95.

What is Foghorn Therapeutics Inc Institutional Holding?

Foghorn Therapeutics Inc Institutional Holding increased by 0.16% in the last quarter to 72.62.

Foghorn Therapeutics Inc XNAS: FHTX

Foghorn Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.05708325
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

4.14 0.00 (0.00%)

59.57% Fall from 52W High

70,400 XNAS Volume

XNAS 23 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

5.8 / 100

Technically Neutral

36.5 / 100

11

1Yr Price target upside is 155%

7 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc FAQ

How is Foghorn Therapeutics Inc today?

Foghorn Therapeutics Inc today is trading in the red, and is down by 0.00% at 4.14.

How has Foghorn Therapeutics Inc performed historically?

Foghorn Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -3.94%. stock has been down -20.84% in the past quarter and fell -33.44% in the past year. You can view this in the overview section.